Uncategorized

The agency proposed new emissions limits that device sterilization companies would have 18 months to meet.

Karuna Therapeutics’ KarXT and Acadia Pharmaceuticals’ pimavanserin are sparking hope that a treatment for the negative symptoms of schizophrenia could be on the horizon.

Hospital lobbies slammed the proposed rule as insufficient to help hospitals address inflation and rising labor costs, though research signals hospitals are more financially stable than such groups suggest.

The amount nonprofit hospitals receive in tax breaks over what they spend on charity care in several states could cover all medical debt for residents, according to the Lown Institute.

BTIG lists 20 companies as competitors to GE HealthCare, including China’s Shenzen Mindray Bio-Medical Electronics and Shanghai United Imaging Healthcare.

Medtech companies are continuing to spin off assets to realign portfolios, creating opportunities for private equity firms to buy businesses and exit existing investments.

Data from two mid-stage studies show HI-Bio’s investigational therapy felzartamab lowers pathogenic antibody titers in patients with primary membranous nephropathy (PMN).

A new open letter from investors Barry Sternlicht, Elliot Cooperstone and Lewis Gold calls on Cano to oust its CEO and sell non-core businesses to focus on profitability.

Transactions were buoyed by a strong first half of the year, with PE deals declining in the second half due to tensions from Russia’s invasion of Ukraine, rising Federal Reserve interest rates and growing inflationary pressures.

In an open letter published Monday, more than 480 biopharma industry leaders expressed their support for the FDA after a Texas federal judge ruled to hold the approval of the abortion pill mifepristone.